ET-A and ET-B receptors — Drug Target

All drugs that target ET-A and ET-B receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

endothelin receptor antagonist

Phase 2 pipeline (1)

• ACT-128800 · Actelion · endothelin receptor antagonist · Cardiovascular
  ACT-128800 is an endothelin receptor antagonist that blocks the action of endothelin-1, a potent vasoconstrictor.